Recordati Industria Chimica e Farmaceutica SPA(IT:REC)
€52.50+0.05 (+0.10%)
IT:REC
Recordati Industria Chimica e Farmaceutica SPA earnings date
€52.50
At close:+0.05 (+0.10%)
Want to see IT:REC full AI Analyst Report?
Recordati Industria Chimica e Farmaceutica SPA (REC) Q3 2022 Earnings Report
17 Followers
IT:REC Q3 2022 EPS Results
- Actual EPS
- EUR 0.63
- Consensus EPS
- EUR 0.45
- Beat/Miss
- Beat by +EUR 0.18
- One Year Ago EPS
- EUR 0.46
IT:REC Q3 2022 Revenue Results
- Actual Revenue
- EUR 485.05M
- Expected Revenue
- EUR 402.94M
- Beat/Miss
- Beat by +EUR 82.11M
- YoY Revenue Growth
- +25.87%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 11/08/2022
- Time
- Before Open
- Conference Call
- Tuesday, November 8, 2022
IT:REC Upcoming Earnings
Recordati Industria Chimica e Farmaceutica SPA's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
IT:REC Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | ―- | 0.57 | ― | ― |
| Nov 10, 2026 | 2026 (Q3) | ―0.67 | 0.79 | -15.82% (-0.13) | |
| Jul 28, 2026 | 2026 (Q2) | ―1.29 | 1.03 | 25.07% (+0.26) | |
| May 12, 2026 | 2026 (Q1) | ―0.73 | 0.6 | 22.41% (+0.13) | |
| Feb 17, 2026 | 2025 (Q4) | 0.730.57 | 0.38 | 51.45% (+0.20) | |
| Nov 11, 2025 | 2025 (Q3) | ―0.79 | 0.69 | 14.49% (+0.10) | |
| Jul 29, 2025 | 2025 (Q2) | 0.771.03 | 0.67 | 54.18% (+0.36) | |
| May 08, 2025 | 2025 (Q1) | ―0.60 | 0.59 | 1.18% (+0.01) | |
| Feb 13, 2025 | 2024 (Q4) | ―0.38 | 0.41 | -7.79% (-0.03) | |
| Nov 08, 2024 | 2024 (Q3) | 0.680.69 | 0.57 | 21.05% (+0.12) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
